159 related articles for article (PubMed ID: 7915960)
1. Synergistic effects of anti-gp330 and anti-dipeptidyl peptidase type IV antibodies in the induction of glomerular damage.
van Leer EH; de Roo GM; Bruijn JA; Hoedemaeker PJ; de Heer E
Exp Nephrol; 1993; 1(5):292-300. PubMed ID: 7915960
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to purified renal tubular epithelial antigens contain activity against laminin, fibronectin, and type IV collagen.
Hogendoorn PC; Bruijn JA; vd Broek LJ; De Heer E; Foidart JM; Hoedemaeker PJ; Fleuren GJ
Lab Invest; 1988 Mar; 58(3):278-86. PubMed ID: 3279261
[TBL] [Abstract][Full Text] [Related]
3. Redistribution of glomerular dipeptidyl peptidase type IV in experimental lupus nephritis. Demonstration of decreased enzyme activity at the ultrastructural level.
van Leer EH; Bruijn JA; Prins FA; Hoedemaeker PJ; de Heer E
Lab Invest; 1993 May; 68(5):550-6. PubMed ID: 8098785
[TBL] [Abstract][Full Text] [Related]
4. Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.
Van Leer EH; Ronco P; Verroust P; van der Wal AM; Hoedemaeker PJ; De Heer E
Am J Pathol; 1993 Mar; 142(3):821-9. PubMed ID: 7681258
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
Susani M; Schulze M; Exner M; Kerjaschki D
Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
[TBL] [Abstract][Full Text] [Related]
6. Identification of gp108, a pathogenic antigen of passive Heymann nephritis, as dipeptidyl peptidase IV.
Natori Y; Hayakawa I; Shibata S
Clin Exp Immunol; 1987 Nov; 70(2):434-9. PubMed ID: 2892601
[TBL] [Abstract][Full Text] [Related]
7. Role of dipeptidyl peptidase IV (gp 108) in passive Heymann nephritis. Use of dipeptidyl peptidase IV-deficient rats.
Natorio Y; Hayakawa I; Shibata S
Am J Pathol; 1989 Feb; 134(2):405-10. PubMed ID: 2563637
[TBL] [Abstract][Full Text] [Related]
8. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108.
Natori Y; Hayakawa I; Shibata S
Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192
[TBL] [Abstract][Full Text] [Related]
9. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
[TBL] [Abstract][Full Text] [Related]
10. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
Makker SP; Tramontano A
J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to glomerular antigens.
Ronco P; Sahali D; Cittanova ML; van Leer EH; Chatelet F; Verroust P
Nephrol Dial Transplant; 1992; 7 Suppl 1():9-15. PubMed ID: 1362802
[No Abstract] [Full Text] [Related]
12. Induction of Heymann nephritis with a gp330/megalin fusion protein.
Raychowdhury R; Zheng G; Brown D; McCluskey RT
Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
[TBL] [Abstract][Full Text] [Related]
13. Glomerular capillary wall charge and antibody binding in passive Heymann nephritis.
Hogendoorn PC; de Heer E; Weening JJ; Daha MR; Hoedemaeker PJ; Fleuren GJ
J Lab Clin Med; 1988 Feb; 111(2):150-7. PubMed ID: 3339269
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma induces dipeptidylpeptidase IV expression in human glomerular epithelial cells.
Stefanovic V; Ardaillou N; Vlahovic P; Placier S; Ronco P; Ardaillou R
Immunology; 1993 Nov; 80(3):465-70. PubMed ID: 7904591
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.
Kerjaschki D; Farquhar MG
J Exp Med; 1983 Feb; 157(2):667-86. PubMed ID: 6337231
[TBL] [Abstract][Full Text] [Related]
16. Characterization and in vivo transfer of nephritogenic autoantibodies directed against dipeptidyl peptidase IV and laminin in experimental lupus nephritis.
Bruijn JA; van Leer EH; Baelde HJ; Corver WE; Hogendoorn PC; Fleuren GJ
Lab Invest; 1990 Sep; 63(3):350-9. PubMed ID: 2395330
[TBL] [Abstract][Full Text] [Related]
17. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.
Ronco P; Allegri L; Brianti E; Chatelet F; Van Leer EH; Verroust P
Appl Pathol; 1989; 7(2):85-98. PubMed ID: 2567175
[TBL] [Abstract][Full Text] [Related]
18. Analysis of glomeruli-eluted Gp330 autoantibodies and of Gp330 antigen of Heymann nephritis.
Makker SP
J Immunol; 1993 Dec; 151(11):6500-8. PubMed ID: 8245481
[TBL] [Abstract][Full Text] [Related]
19. Heymann antibodies induce complement-dependent injury of rat glomerular visceral epithelial cells.
Camussi G; Salvidio G; Biesecker G; Brentjens J; Andres G
J Immunol; 1987 Nov; 139(9):2906-14. PubMed ID: 3312408
[TBL] [Abstract][Full Text] [Related]
20. Detection of two forms of GP330. Their role in Heymann nephritis.
Bachinsky DR; Zheng G; Niles JL; McLaughlin M; Abbate M; Andres G; Brown D; McCluskey RT
Am J Pathol; 1993 Aug; 143(2):598-611. PubMed ID: 8342605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
